No definition available.
Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy
P16_FET_NEWB_MATERN_COND_UNREL_PRESENT_PREGNAC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
145 |
4. Check minimum number of eventsNone |
145 |
5. Include endpointsNone |
145 |
6. Filter based on genotype QC (FinnGen only) |
145 |
Control definitions (FinnGen only)
- Control exclude
- P16_FET_NEWB_MATERN_FACTO_COMPLICATIO_PREGNAC_LABOUR_DELIV
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- P0[0-4]
- Name in latin
- Fetus et neonatus condicionibus matris (etiam ad graviditatem praesentem non pertinentibus) affectus
Similar endpoints
↥List of similar endpoints to
Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy
based on the number of shared cases.
Similar with more cases:
- Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery
- Certain conditions originating in the perinatal period
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 10861 | 5151 | 5709 |
| Only index persons | 4967 | 2381 | 2586 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.15 | 0.15 | 0.16 |
| Only index persons | 0.09 | 0.09 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.00 | 0.00 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 145 | 71 | 74 |
| Unadjusted period prevalence (%) | 0.03 | 0.02 | 0.03 |
| Median age at first event (years) | 0.00 | 0.00 | 0.00 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 130
- Matched controls
- 1301
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
P00.0
ICD-10 Finland
Fetus and newborn affected by maternal hypertensive disorders
+∞
110.8
90
*
P07.3
ICD-10 Finland
Other preterm infants
25.1
39.0
57
39
P00.8
ICD-10 Finland
Fetus and newborn affected by other maternal conditions
+∞
23.7
22
*
Z87.6
ICD-10 Finland
Personal history of certain conditions arising in the perinatal period
13.1
22.3
41
44
P70.4
ICD-10 Finland
Other neonatal hypoglycaemia
12.4
15.4
28
28
P00.2
ICD-10 Finland
Fetus and newborn affected by maternal infectious and parasitic diseases
+∞
12.7
12
*
P07.11
ICD-10 Finland
Other low birth weight 1500-1999 g
25.9
10.5
14
6
P05.0
ICD-10 Finland
Light for gestational age
22.2
10.0
14
7
P01.5
ICD-10 Finland
Fetus and newborn affected by multiple pregnancy
+∞
8.4
8
*
P05.1
ICD-10 Finland
Small for gestational age
11.9
7.5
13
12
P07.12
ICD-10 Finland
Other low birth weight 2000-2499 g
13.1
7.2
12
10
P70.0
ICD-10 Finland
Syndrome of infant of mother with gestational diabetes
10.9
6.7
12
12
P22.1
ICD-10 Finland
Transient tachypnoea of newborn
7.2
6.6
15
23
P01.10
ICD-10 Finland
Fetus and newborn affected by premature rupture of membranes 1-7 days before delivery
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3022411) Androstenedione [Moles/volume] in Serum or Plasma
7
15
4.82
2.62
1.4
2.9
nmol/l
3.3
2.4
—
7
15
(3026820) Hemoglobin [Mass/volume] in Venous cord blood
5
8
6.40
2.38
1.0
1.0
g/l
168.0
154.3
—
5
8
(40765089) Chromosome analysis panel - Blood by G-banded
7
19
3.80
2.17
1.0
1.1
—
—
—
0
0
(3022670) pH of Venous cord blood
6
17
3.62
1.85
1.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
17
91
1.97
1.67
1.4
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
14
3.64
1.62
1.0
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
8
32
2.57
1.61
5.8
6.1
ug/l
1.9
2.3
—
8
32
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
8
163
0.46
1.47
2.0
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
13
231
0.52
1.47
2.5
3.1
kg/l
1.0
1.0
—
6
46
(3003694) ABO and Rh group [Type] in Blood
23
337
0.62
1.29
1.6
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
8
146
0.52
1.11
1.3
2.0
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
9
157
0.54
1.06
1.2
2.0
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
118
0.49
0.99
1.5
2.6
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
0
28
0.00
0.99
0.0
2.6
—
1.7
—
0
28
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
32
0.00
0.96
0.0
5.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
78
1.72
0.94
2.2
2.4
nmol/l
6.1
10.9
—
8
59
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
42
1.95
0.90
1.9
2.0
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
19
267
0.66
0.87
2.3
3.4
ug/g
73.9
78.2
0.05
14
210
(40760892) CBC W Ordered Manual Differential panel - Blood
16
233
0.64
0.87
5.3
6.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
7
124
0.54
0.82
1.3
2.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
10
159
0.60
0.78
1.2
2.0
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
159
0.60
0.78
1.2
1.9
—
—
—
0
0
(3020891) Body temperature
0
27
0.00
0.78
0.0
11.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
27
0.00
0.78
0.0
3.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
27
0.00
0.78
0.0
3.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
158
0.60
0.77
1.2
2.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
11
169
0.62
0.76
1.6
1.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
22
292
0.71
0.75
2.3
2.1
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
14
93
1.55
0.71
2.7
2.5
iu/l
4.4
7.5
—
7
61
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
189
0.65
0.71
1.4
1.8
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
111
1174
0.75
0.69
16.2
17.1
%
39.8
38.9
1.44
104
1045
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
21
277
0.71
0.69
2.6
3.6
—
—
—
0
0
(3027901) Hemoglobin [Mass/volume] in Arterial cord blood
7
43
1.65
0.67
1.0
1.0
g/l
173.6
161.4
—
7
43
(3005322) IgE [Units/volume] in Serum or Plasma
10
152
0.63
0.66
2.4
1.5
u/ml
161.3
414.6
—
10
138
(3009214) Lutropin [Units/volume] in Serum or Plasma
15
104
1.49
0.64
2.6
2.5
u/l
6.7
5.7
—
7
71
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
20
262
0.72
0.63
2.1
2.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
52
597
0.79
0.63
5.5
4.1
—
35.9
—
0
8
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
0
20
0.00
0.61
0.0
1.7
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
0
20
0.00
0.61
0.0
5.6
—
1.5
—
0
20
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
7.0
—
—
—
0
0
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
0
21
0.00
0.60
0.0
5.1
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
29
356
0.76
0.60
3.1
4.9
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
22
0.00
0.60
0.0
9.2
—
2.1
—
0
17
(3042936) Bacteria identified in Isolate by Culture
8
121
0.64
0.57
1.6
1.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
12
169
0.68
0.57
2.8
1.8
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
90
823
1.23
0.56
3.4
3.3
pmol/l
14.2
14.5
0.53
85
755
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
22
278
0.75
0.56
2.2
2.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
37
436
0.79
0.55
8.0
9.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
14
190
0.71
0.55
2.0
2.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
15
200
0.72
0.53
2.4
1.6
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
67
737
0.82
0.51
6.9
11.1
e9/l
2.6
2.4
0.57
54
618
(3044889) 12 lead EKG panel
47
406
1.23
0.50
2.0
2.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
49
553
0.82
0.48
1.5
1.9
u/ml
2.0
3.2
—
7
90
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
12
85
1.44
0.47
1.0
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
84
0.58
0.47
2.0
1.8
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
49
1.44
0.46
1.1
1.2
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
57
632
0.83
0.46
4.8
4.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
162
0.71
0.46
2.0
1.6
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
39
448
0.82
0.46
3.7
3.6
estimate
0.0
0.0
—
5
76
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
9
126
0.69
0.45
3.9
9.7
%
91.3
89.0
—
9
126
(3005719) IgG [Mass/volume] in Serum or Plasma
11
150
0.71
0.45
1.8
4.4
g/l
9.8
8.5
0.84
11
144
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
14
183
0.74
0.45
2.0
2.2
mmol/l
1.2
1.4
0.69
14
170
(4010399)
8
56
1.45
0.43
1.8
1.5
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
39
445
0.83
0.42
6.1
5.2
estimate
0.0
0.0
—
5
80
(3007164) IgA [Mass/volume] in Serum or Plasma
47
526
0.84
0.41
1.5
1.7
g/l
1.6
1.5
0.04
16
255
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
5
33
1.53
0.41
1.4
1.5
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
33
1.53
0.41
6.4
3.8
umol/l
23.0
27.6
—
5
33
(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
15
0.00
0.41
0.0
7.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
16
0.00
0.41
0.0
4.1
—
—
—
0
0
(3004959) Base excess in Arterial cord blood by calculation
11
79
1.42
0.41
1.0
1.0
mmol/l
-4.4
-3.0
—
5
33
(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood
11
79
1.42
0.41
1.0
1.0
mmol/l
18.1
19.5
0.62
11
79
(3006598) pH of Arterial cord blood
11
79
1.42
0.41
1.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
105
0.65
0.41
1.0
2.0
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
14
180
0.75
0.40
1.1
1.4
—
47.5
—
0
6
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
34
1.48
0.40
2.4
1.8
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.8
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(3024471) HLA-A [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
19
0.00
0.39
0.0
6.6
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
19
0.00
0.39
0.0
6.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
5
36
1.40
0.38
1.0
1.1
—
4.1
—
0
11
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
2.6
1.9
—
—
—
0
0
(3000991) Gas panel - Venous blood
32
273
1.21
0.38
8.0
14.7
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
67
723
0.86
0.37
6.9
11.1
e9/l
0.6
0.6
0.41
52
584
(3003740) Influenza virus B Ag [Presence] in Specimen
6
41
1.48
0.36
1.2
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
80
0.61
0.36
1.4
2.2
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
42
1.44
0.36
1.2
1.2
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
67
721
0.86
0.35
6.9
11.1
e9/l
0.0
0.0
0.32
52
583
(21494755) Public health laboratory ask at order entry panel
6
44
1.37
0.35
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
10
74
1.37
0.32
2.2
1.9
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
7
51
1.39
0.32
1.1
1.1
—
4.4
—
0
7
(3013650) Neutrophils [#/volume] in Blood by Automated count
71
756
0.87
0.31
7.9
13.3
e9/l
3.4
3.4
0.06
54
621
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
7
53
1.33
0.31
2.1
2.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
109
1127
0.85
0.31
12.4
12.2
mg/l
25.0
23.8
0.11
76
742
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
8
105
0.74
0.30
3.4
8.4
%
121.3
173.7
—
8
105
(3026493) Urate [Moles/volume] in Serum or Plasma
9
117
0.75
0.28
2.1
7.0
umol/l
287.2
274.2
—
9
109
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
61
563
1.14
0.28
16.0
14.2
mmol/l
1.2
1.2
0.11
56
525
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
20
168
1.22
0.28
2.1
6.8
mg/l
1.1
2.1
0.75
13
123
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
8
64
1.26
0.28
1.0
1.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
10
127
0.77
0.27
1.4
1.4
%
1.3
1.4
—
10
114
(3011397) Hemoglobin [Presence] in Urine by Test strip
25
285
0.85
0.27
4.2
3.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
30
264
1.17
0.26
2.2
4.3
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
18
211
0.83
0.26
3.2
4.5
inr
1.1
1.2
—
7
57
(3025941) Bacteria identified in Stool by Culture
5
37
1.36
0.24
1.2
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
39
354
1.13
0.23
5.6
4.8
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
15
125
1.22
0.22
3.1
2.7
ng/l
8.1
18.3
—
8
52
(3009445) Proteinase 3 Ab [Units/volume] in Serum
5
40
1.25
0.22
1.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
21
182
1.17
0.22
5.6
4.9
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
55
585
0.90
0.22
2.4
2.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
10
123
0.80
0.22
1.9
2.2
g/l
1.0
0.9
—
10
116
(3013512) EKG study
8
101
0.78
0.22
2.1
2.8
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
5
42
1.19
0.21
1.4
1.2
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
207
0.85
0.21
2.1
1.7
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
0
11
0.00
0.21
0.0
1.2
—
4567.2
—
0
6
(3044941) Cell count panel - Synovial fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
0
12
0.00
0.21
0.0
3.6
—
31.3
—
0
12
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
12
0.00
0.21
0.0
9.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
27.2
—
0.6
—
0
12
(3013115) Eosinophils [#/volume] in Blood
70
734
0.90
0.21
7.6
12.0
e9/l
0.2
0.2
1.15
57
611
(3021589) Normoblasts [#/volume] in Blood
67
704
0.90
0.21
9.2
12.9
e9/l
0.0
0.0
0.50
46
517
(3015736) pH of Urine
33
361
0.88
0.21
3.5
3.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
0
13
0.00
0.21
0.0
3.3
—
—
—
0
0
(3008092) Baker's yeast IgG Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.5
—
16.4
—
0
5
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
6
48
1.26
0.20
10.2
25.8
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
16
185
0.84
0.20
2.2
3.4
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(4035726)
6
50
1.20
0.20
1.5
2.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
51
1.18
0.19
2.3
1.9
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
56
591
0.91
0.19
2.1
2.2
mmol/l
5.4
5.4
0.04
50
543
(3023511) Choriogonadotropin [Units/volume] in Urine
7
59
1.19
0.18
1.3
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
7
60
1.17
0.18
1.3
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
6
76
0.78
0.16
1.5
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
50
527
0.92
0.16
6.2
7.4
ml/min/173m2
114.8
114.7
0.02
35
310
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
79
0.75
0.16
1.5
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
130
1.17
0.15
2.5
2.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
7
88
0.78
0.15
2.0
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
69
715
0.93
0.14
6.9
11.3
%
8.4
8.5
0.16
64
690
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
93
1.19
0.14
1.0
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
38
354
1.09
0.14
5.8
4.8
e6/l
0.0
0.2
2.18
27
256
(3024561) Albumin [Mass/volume] in Serum or Plasma
31
330
0.92
0.12
8.4
10.5
g/l
35.5
37.3
0.80
31
318
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
13
146
0.88
0.11
4.2
8.5
umol/l
6.6
8.0
—
7
125
(3022313) Gas panel - Capillary blood
30
279
1.09
0.11
20.0
10.2
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
36
339
1.08
0.10
20.6
16.5
mmol/l
24.8
24.8
0.03
36
339
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
18
196
0.90
0.10
1.4
3.2
u/l
69.3
64.5
0.10
18
180
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
5
43
1.16
0.10
3.4
1.3
—
—
—
0
0
(44790049)
5
43
1.16
0.10
1.2
2.0
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
5
43
1.16
0.10
3.4
1.3
—
—
—
0
0
(44806118)
5
43
1.16
0.10
1.2
2.0
—
—
—
0
0
(44790047)
5
43
1.16
0.10
1.2
2.0
—
—
—
0
0
(44790048)
5
43
1.16
0.10
1.2
2.0
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
5
44
1.14
0.10
3.0
4.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
40
379
1.07
0.10
5.5
5.0
e6/l
17.0
29.3
0.47
29
283
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
46
1.09
0.09
3.0
3.8
e6/l
572.0
533.4
—
5
29
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
5
46
1.09
0.09
3.0
3.8
e9/l
0.6
0.2
—
5
29
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
5
47
1.06
0.09
2.0
2.3
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
47
1.06
0.09
3.0
4.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
5
47
1.06
0.09
3.0
4.2
e9/l
1.8
1.6
—
5
30
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
33
311
1.07
0.09
19.4
10.7
mmol/l
1.3
1.2
0.11
22
227
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
6
54
1.11
0.09
12.0
25.9
mmol/l
22.8
24.5
—
6
54
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
55
1.09
0.09
1.2
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
5
62
0.80
0.08
4.0
2.5
pmol/l
5.9
5.2
—
5
54
(3009508) Creatinine [Moles/volume] in Urine
26
275
0.93
0.08
2.7
5.1
mmol/l
9.2
8.7
0.15
26
265
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
64
1.09
0.08
2.3
1.8
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
64
1.09
0.08
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
6
71
0.83
0.08
2.0
1.5
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
6
74
0.80
0.08
3.2
3.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
119
1200
0.93
0.07
3.9
3.7
—
—
—
0
0
(3009343) pH of Capillary blood
33
313
1.06
0.07
19.4
10.8
—
7.4
—
0
12
(3020779) Urea [Moles/volume] in Serum or Plasma
18
193
0.92
0.07
9.4
14.3
mmol/l
4.9
4.9
0.02
18
188
(3023520) Reticulocytes [#/volume] in Blood
15
137
1.10
0.07
3.3
6.4
e9/l
55.9
62.7
—
9
89
(3000494) Fungus identified in Specimen by Culture
9
99
0.90
0.06
6.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
18
191
0.93
0.05
2.4
1.6
pmol/l
84.4
97.4
—
6
100
(3003338) MCHC [Mass/volume]
112
1128
0.95
0.05
15.1
16.8
g/l
336.8
335.5
0.81
112
1111
(3018095) Leukocytes [#/volume] in Urine
45
436
1.04
0.04
6.8
5.9
e6/l
51.7
33.8
0.21
30
290
(1761868) Lipid panel - Serum or Plasma
16
169
0.94
0.04
1.8
2.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
16
169
0.94
0.04
1.1
1.1
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
22
229
0.95
0.03
4.6
2.5
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
109
1096
0.96
0.03
8.7
7.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
131
1.07
0.03
2.6
2.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
24
230
1.05
0.03
5.4
4.4
e6/l
0.7
0.6
0.11
13
125
(3002385) Erythrocyte distribution width [Ratio]
110
1105
0.96
0.03
16.2
17.8
%
13.3
13.1
0.44
110
1088
(3020682) Albumin/Creatinine [Ratio] in Urine
10
93
1.08
0.01
3.8
4.1
mg/mmol
8.5
10.3
—
10
84
(42870588) Differential panel, method unspecified - Blood
58
584
0.98
0.01
6.9
11.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
18
185
0.96
0.00
3.6
9.2
%
1.7
1.3
0.55
18
179
(3007461) Platelets [#/volume] in Blood
130
1289
1.04
0.00
15.7
17.6
e9/l
274.4
273.0
0.08
120
1216
(3012516) Albumin [Mass/volume] in Urine
10
94
1.06
0.00
2.8
3.6
mg/l
81.0
138.8
—
10
84
(3010813) Leukocytes [#/volume] in Blood
130
1291
1.03
0.00
15.6
17.5
e9/l
7.2
6.9
0.92
119
1210
(36660697) Celiac disease serology panel - Serum
24
237
1.01
0.00
1.3
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
23
233
0.98
0.00
2.4
4.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
40
401
0.99
0.00
5.6
5.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
34
344
0.98
0.00
1.9
2.0
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
154
0.97
0.00
2.6
2.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
130
1290
1.03
0.00
15.6
17.5
e12/l
4.7
4.6
1.49
120
1213
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
235
1.02
0.00
5.4
4.4
e6/l
0.7
1.9
1.38
13
132
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
0
7
0.00
0.00
0.0
7.9
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
5
55
0.90
0.00
14.2
25.7
%
98.0
95.1
—
5
55
(40758292) HTLV I+II Ab panel - Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
9.5
—
0
8
(40768793) Breast Pathology biopsy report
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
7
0.00
0.00
0.0
5.0
—
4.2
—
0
7
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
9.5
—
0
9
(3027305) Fractional oxyhemoglobin in Arterial cord blood
0
5
0.00
0.00
0.0
1.0
—
33.5
—
0
5
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
68
0.87
0.00
2.8
1.2
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
6
66
0.90
0.00
1.7
1.5
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
435.5
—
0
6
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
5.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40760512) CD34 cells/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.0
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.8
—
1.4
—
0
8
(3009410) PHENobarbital [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
15.6
—
97.0
—
0
5
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
5
58
0.85
0.00
14.2
24.5
%
0.7
0.7
—
5
58
(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
76.3
—
0
6
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
7
0.00
0.00
0.0
8.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000012) Reticulocyte production index
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
109.9
—
0
9
(3032641) Amino acids panel - Urine
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
5
58
0.85
0.00
14.2
24.5
%
0.8
1.1
—
5
58
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
76
0.91
0.00
2.1
2.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
134.6
—
0
5
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
5
51
0.98
0.00
3.0
3.7
e6/l
714.0
404.1
—
5
32
(3004716) Salmonella sp identified in Stool by Organism specific culture
9
94
0.95
0.00
1.2
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.2
—
3.8
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint P16_FET_NEWB_MATERN_COND_UNREL_PRESENT_PREGNAC and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have P16_FET_NEWB_MATERN_COND_UNREL_PRESENT_PREGNAC.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: P16_FET_NEWB_MATERN_COND_UNREL_PRESENT_PREGNAC – Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data